Coronaria Oy Supplements the Tender Offer Document Relating to the Public Tender Offer for All Shares Issued by Silmäasema Plc

Silmäasema Oyj                
Inside Information
9 September 2019 at 7:30 p.m. EET

Silmäasema has received the following information regarding Coronaria’s mandatory public tender offer for all shares in Silmäasema Oyj:

As announced previously Coronaria Oy (“Coronaria” or the “Offeror”) has on September 5, 2019 commenced a mandatory public tender offer to purchase all of the issued and outstanding shares in Silmäasema Oyj (“Silmäasema”) that are not held by Coronaria, Silmäasema or any of its subsidiaries (the “Tender Offer”). The acceptance period under the Tender Offer commenced on September 5, 2019 at 9:30 a.m. (Finnish time) and will expire on September 26, 2019 at 4:00 p.m. (Finnish time) (the “Offer Period”). The Offeror reserves the right to extend the Offer Period in accordance with the terms and conditions of the Tender Offer.

The Finnish Financial Supervisory Authority has today approved a supplement to the tender offer document relating to the Tender Offer (the “Supplement Document”). The Offeror has corrected the offer price to represent a premium of approximately 10.4 per cent compared to the volume-weighted average trading price during the 6-month period preceding the triggering of the obligation to launch the Tender Offer.

In addition, the Offeror has supplemented Section 4.1 of the tender offer document with Silmäasema's stock exchange release “Silmäasema Oyj: Silmäasema’s new strategy and updated financial targets – renewing the eyesight market and growing profitably” dated August 16, 2019. The stock exchange release is added as Annex D to the tender offer document.

The tender offer document will be available with the Supplement Document in Finnish from September 9, 2019 onwards at the headquarters of Coronaria, Saaristonkatu 22, 3rd floor, FI-90100 Oulu, Finland, at Carnegie Investment Bank AB, Finland branch, Eteläesplanadi 22 A, 7th floor, FI-00130 Helsinki, Finland and at Nasdaq Helsinki Ltd., Fabianinkatu 14, FI-00100 Helsinki, Finland. The electronic version of the tender offer document will be available with the Supplement Document in Finnish from September 9, 2019 onwards online at www.coronaria.fi/ostotarjous and www.carnegie.se/ostotarjous and in English from September 9, 2019 onwards online at www.coronaria.fi/tender-offer and www.carnegie.se/tenderoffer.

Silmäasema’s operations will continue as normal and the transaction has no impact on our customers.


SILMÄASEMA OYJ

Jussi Salminen
CEO


For further information, please contact:

CEO Jussi Salminen, tel. +358 40 834 5818
CFO Sari Nordblad, tel. +358 50 552 7247


Mikko Merisaari, Head of Communications and Investor Relations, tel. +358 50 521 4055

Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as nine stores in Estonia. The Silmäasema chain employs over 1,000 eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.